Cardinal Health Sets Fiscal 2027 EPS Growth Target of 13%-15%
Cardinal Health (NYSE:CAH) has set a target for adjusted earnings-per-share growth of 13% to 15% in fiscal 2027, driven by operating-income gains across its business segments. The company reiterated its long-term EPS growth goal of 12%-14%, supported by continued momentum from its specialty services and BioPharma Solutions division. Specialty services are expected to remain a key driver after growing 25% in fiscal 2026, with double-digit expansion anticipated for the next year. The company also aims to reach $1 billion in revenue through BioPharma by fiscal 2028 and plans $1 billion in share repurchases as part of its capital return strategy. Cardinal Health's CEO Jason Hollar highlighted strong performance across profit, cash flow, and operating momentum from the prior year. The company is also focused on expanding within oncology, urology, and autoimmune care while pursuing strategic acquisitions that align with existing platforms.
Tickers: $CAH
Topics: BioPharma Solutions EPS growth share repurchases specialty services